Total Payments
$3,072
2024 Payments
$139.70
Companies
10
Transactions
48
Medicare Patients
3,260
Medicare Billing
$877,814
Payment Breakdown by Category
Food & Beverage$1,672 (54.4%)
Travel$1,400 (45.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,672 | 43 | 54.4% |
| Travel and Lodging | $1,400 | 5 | 45.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Laboratories Inc | $1,244 | 4 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $874.20 | 11 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $274.30 | 11 | $0 (2023) |
| Genentech USA, Inc. | $191.93 | 10 | $0 (2023) |
| Dompe US, Inc. | $139.70 | 1 | $0 (2024) |
| Allergan Inc. | $134.87 | 3 | $0 (2018) |
| Alimera Sciences, Inc. | $103.79 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $74.26 | 5 | $0 (2019) |
| ABBVIE INC. | $23.07 | 1 | $0 (2022) |
| Alcon Vision LLC | $12.37 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.70 | 1 | Dompe US, Inc. ($139.70) |
| 2023 | $45.51 | 2 | Regeneron Healthcare Solutions, Inc. ($29.87) |
| 2022 | $111.47 | 5 | Regeneron Healthcare Solutions, Inc. ($88.40) |
| 2021 | $106.06 | 4 | Regeneron Healthcare Solutions, Inc. ($106.06) |
| 2020 | $42.25 | 2 | Regeneron Healthcare Solutions, Inc. ($29.88) |
| 2019 | $101.03 | 6 | Novartis Pharmaceuticals Corporation ($45.86) |
| 2018 | $2,407 | 26 | Alcon Laboratories Inc ($1,244) |
| 2017 | $119.05 | 2 | Allergan Inc. ($119.05) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $139.70 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/10/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/09/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/20/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/18/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/25/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: RETINA | ||||||
| 04/05/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/19/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/16/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/02/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/06/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/13/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/01/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/24/2020 | Alcon Vision LLC | Centurion (Device), AcrySof | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Ophthalmology | ||||||
| 11/19/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug), BEPREVE, ALREX | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/08/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/04/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/10/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.86 | General |
| 06/21/2019 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/08/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Ophthalmology | ||||||
| 11/16/2018 | Alcon Laboratories Inc | — | Travel and Lodging | Cash or cash equivalent | $445.62 | General |
| 11/16/2018 | Alcon Laboratories Inc | DAILIES (Device) | Travel and Lodging | Cash or cash equivalent | $351.15 | General |
| Category: Ophthalmology | ||||||
| 11/16/2018 | Alcon Laboratories Inc | — | Food and Beverage | In-kind items and services | $283.58 | General |
| 11/16/2018 | Alcon Laboratories Inc | — | Travel and Lodging | Cash or cash equivalent | $163.54 | General |
| 11/16/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 248 | 347 | $76,714 | $21,503 |
| 2022 | 14 | 1,108 | 2,106 | $676,000 | $291,764 |
| 2021 | 13 | 1,068 | 2,153 | $720,750 | $323,499 |
| 2020 | 11 | 836 | 1,505 | $561,470 | $241,047 |
Total Patients
3,260
Total Services
6,111
Medicare Billing
$877,814
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 76 | 105 | $25,789 | $9,243 | 35.8% |
| 92134 | Imaging of retina | Office | 2023 | 82 | 120 | $13,040 | $3,726 | 28.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 17 | 38 | $12,826 | $3,459 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $17,375 | $3,396 | 19.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 11 | 14 | $2,955 | $886.19 | 30.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 21 | 29 | $3,023 | $604.56 | 20.0% |
| 92250 | Photography of the retina | Office | 2023 | 16 | 16 | $1,706 | $188.17 | 11.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 21 | 240 | $360,000 | $167,298 | 46.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 204 | 368 | $64,400 | $35,201 | 54.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 47 | 198 | $67,350 | $19,712 | 29.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 133 | 178 | $35,600 | $16,585 | 46.6% |
| 92134 | Imaging of retina | Office | 2022 | 200 | 411 | $41,100 | $12,496 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 151 | $30,200 | $11,967 | 39.6% |
| J3590 | Unclassified biologics | Office | 2022 | 28 | 109 | $21,800 | $8,094 | 37.1% |
| 92250 | Photography of the retina | Office | 2022 | 189 | 255 | $25,500 | $6,903 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $9,900 | $4,064 | 41.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 44 | 52 | $6,500 | $3,696 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 45 | $6,750 | $2,858 | 42.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 24 | 24 | $4,800 | $1,996 | 41.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 24 | 31 | $1,550 | $712.03 | 45.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 11 | 11 | $550.00 | $183.90 | 33.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 22 | 262 | $393,000 | $191,770 | 48.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 303 | $60,600 | $31,662 | 52.2% |
| 67028 | Injection of drug into eye | Office | 2021 | 45 | 223 | $72,550 | $22,430 | 30.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 143 | 230 | $40,250 | $20,640 | 51.3% |
About Dr. Benjamin Reinherz, D.O
Dr. Benjamin Reinherz, D.O is a Ophthalmology healthcare provider based in North Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1124422175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Reinherz, D.O has received a total of $3,072 in payments from pharmaceutical and medical device companies, with $139.70 received in 2024. These payments were reported across 48 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,672).
As a Medicare-enrolled provider, Reinherz has provided services to 3,260 Medicare beneficiaries, totaling 6,111 services with total Medicare billing of $877,814. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Retina Specialist
- Location North Miami, FL
- Active Since 10/20/2014
- Last Updated 03/22/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1124422175
Products in Payments
- STELLARIS (Device) $834.33
- DAILIES (Device) $351.15
- EYLEA (Biological) $274.30
- Lucentis (Biological) $176.29
- OZURDEX (Drug) $157.94
- OXERVATE (Drug) $139.70
- DUREZOL (Drug) $30.99
- LOTEMAX SM (Drug) $21.73
- BESIVANCE (Drug) $18.14
- TRAVATAN Z (Drug) $17.36
- Vabysmo (Drug) $15.64
- Centurion (Device) $12.37
- BEOVU (Drug) $12.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.